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Review question(s)
• What risk factors are associated with mortality in T1DM?
• How do these risk factors affect mortality rates in individuals diagnosed with T1DM as compared to the general
population?
• Are there any gender difference in individuals diagnosed with T1DM?
Searches
Relevant studies will be searched for regardless of publication status i.e. published and unpublished studies. 
An initial search will cover electronic databases such as PubMed, MEDLINE, Campbell Library of Systematic
Reviews, Cochrane Database of Systematic Reviews (CDSR), EMBASE and PAIS International, the Cochrane
Central Register of Controlled Trials (CENTRAL), LILACS, World Health Organisation Library and Information
Network for Knowledge database (WHOLIS), The Centre for Evidenced-Based Medicine, PsycINFO, Google
Scholar, National Library for Health, Ongoing Reviews database, British Nursing Index and Scopus (Higgins &
Green, 2011). 
The search for unpublished works will be done through assessing grey literature such as UK National Research
Register (NRR), ReFeR, Kings Fund and Conference Papers Index. FADE, ProQuest Dissertation and mTheses, and
other Indexed Citations up to 2015, National Technical Information Service (NTIS) and Health Management
Information Service. 
A manual search will be undertaken of reference lists of all studies identified by the above methods.
Non-English language databases like the LILACS (Latin American and Caribbean Health Sciences) will be assessed
provided they are translated into English language to reduce the risk of language bias (CRD, 2008). Bibliographic
databases such as BIOSIS will also be assessed for previews of materials from conferences. 
The search strategy will involve using keywords and phrases, including Medical Subject Headings (MeSH) related to
the inclusion criteria for the study. 
The search period instituted will be between January, 1960 and March, 2016.
Types of study to be included
• Existing systematic reviews;
• Epidemiological studies; 
• Randomised controlled trials of interventions in the management of T1DM.
Condition or domain being studied
Mortality in type 1 diabetes.
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Participants/ population
Participants diagnosed with T1DM before the age of 40 years as it becomes increasingly difficult to differentiate
between type 1 and type 2 diabetes after this age.
Intervention(s), exposure(s)
The nature of the outcome to be reviewed in this study is mortality after the diagnosis of type 1 diabetes. 
Exclusions are as follows;
(1) Any study that has a CASP score (Quality appraisal) less than 8;
(2) Studies in which the participants acquire type 1 diabetes from a secondary cause;
(3) Studies that only have an abstract and the full paper is not accessible;
(4) Studies in which there is no differentiation between type 1 or type 2 diabetes in participants;
(5) Studies that do not have any comparison population (either cohort or general population); 
(6) Studies without adequate data for analysis.
Comparator(s)/ control
The studies included will have a comparison population which will be either a comparison cohort or the general
population.
Outcome(s)
Primary outcomes
Overall mortality rate/all-cause mortality. 
The outcome measures used will be the standardized mortality ratio (SMR) as a form of relative risk (RR).
Secondary outcomes
Secondary outcomes include mortality in relation to:
1. Gender;
2. Year of study publication;
3. Follow-up duration;
4. Cause (overall and according to gender);
a) Cardiovascular disease (inclusive of coronary artery disease, myocardial infarction, heart failure/disease, ischemic
heart disease);
b) Cerebrovascular disease (stroke);
c) Renal disease;
d) Cancer;
e) Accidents and suicide.
Data extraction, (selection and coding)
This process entails retrieving the information needed from the studies included in this review. The process can be
carried out manually or electronically (CRD, 2008). Forms will be developed, modified, and adapted to the CRD
template (CRD, 2008). The following data will be extracted from individually selected studies: author, year of
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publication, study design, setting/location, year of study, comparison population, study size, number of deaths,
patients’ characteristics, follow-up years, outcome measure(s) of mortality, and degree of mortality in standardized
mortality ratios (SMRs). The process of data extraction will be carried out by one reviewer (AE) any discrepancies
will be addressed by two other reviewers (HC) and (DBJ).
Risk of bias (quality) assessment
Having ensured that studies meet the inclusion/exclusion criteria, the next stage will be to quality appraise the studies
using the Critical Appraisal Skill Programme [CASP] tool (Higgins & Green, 2011). The CASP tool uses a check list
that assesses systematic reviews, randomized control trials, case controls and cohort studies. The process will be
documented and each study will be scored. This process will be carried out by one reviewer (AE) and triangulated by
(HC) and (DBJ). CASP scores will be assigned to the study and any study scoring less than 9 out of an overall score
of 12 will be excluded from the quantitative analysis. 
The quality appraisal will assess the following three broad categories:
• Are the results valid? 
• What are the results?
• Will the results help locally?
Strategy for data synthesis
We intend to conduct a narrative synthesis on the studies included in tabular format. This table will include a
synthesis of the studies included, a consideration of factors such as study characteristics/type, study participants
characteristics, settings and outcomes measured. We will also calculate the risk ratios using standardized mortality
ratios (SMR) as a form of relative risk. The estimations of risk ratios (RR) will involve calculating the log (SMR) and
standard errors (SE), back transformed to estimate the risk ratios (RR) at 95% confidence limits using the statistical
software Review Manager version 5.3. We also intend to conduct a meta-analysis using the outcomes identified,
estimating the average pooled effect estimate of the studies included at 95% confidence intervals. The analysis for
this study will be either a random or a fixed-effect meta-analysis. It is anticipated that for a study of this nature, there
will exist a certain amount of heterogeneity of the studies included because of variations in study populations,
settings, and outcome measures. We intend to measure heterogeneity between study characteristics by assessing the I-
squared estimate. Any values greater than 60% will considered as having significant levels of heterogeneity and an
exclusion sensitivity analysis will be carried out to find out which studies contribute to the degree of heterogeneity
observed.
Analysis of subgroups or subsets
We intend to conduct subgroup meta-analyses based on year of study publication and follow-up duration. 
The follow-up duration will be categorized into follow-up durations of less than 10 years, between 10 and 20 years
and greater than 20 years. Assessing the subgroup analysis on follow-up duration will be done as a proxy to estimate
survival with disease progression. 
Subgroup analysis based on study publication will consider publication years before the year 2000, publications
between 2000 and 2010, and publications after the year 2010. This analysis will be done as a proxy to estimate the
temporal trend in the management of type 1 diabetes.
Dissemination plans
We intend to communicate the essential messages of this review in conferences, and seminar meetings.
Contact details for further information
Eloho Akata
9 Bouverie Street, Chester, CH1 4HF, Cheshire
eloho3@yahoo.co.uk
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Organisational affiliation of the review
Department of Public Health and Wellbeing, Faculty of Health and Social Care, University of Chester
www.chester.ac.uk/health/phw
Review team
Dr Eloho Akata,
Dr Andi Mabhala, Department of Public Health and Wellbeing, Faculty of Health and Social Care, University of
Chester
Professor Helen Cooper, Professor, Public Health and Wellbeing,Department of Public Health and Wellbeing,
Faculty of Health and Social Care, University of Chester
Professor David-Bowen Jones, Wirral University Teaching Hospital
Anticipated or actual start date
02 November 2015
Anticipated completion date
29 May 2016
Funding sources/sponsors
None
Conflicts of interest
None known
Language
English
Country
England
Subject index terms status
Subject indexing assigned by CRD
Subject index terms
Diabetes Mellitus, Type 1; Epidemiology; Humans; Mortality; Risk Factors
Any other information
This review is being undertaken as part of a PhD project in type 1 diabetes. AE, HC and DBJ are investigators for the
proposed systematic review. AE and HC proposed the study, HC, DBJ, and MA are reviewers and supervisors of the
study.
Stage of review
Ongoing
Date of registration in PROSPERO
11 April 2016
Date of publication of this revision
11 April 2016
Stage of review at time of this submission Started Completed
Preliminary searches Yes   Yes 
Piloting of the study selection process   Yes   Yes 
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Formal screening of search results against eligibility criteria   Yes   Yes 
Data extraction   Yes   No 
Risk of bias (quality) assessment   No   No 
Data analysis   No   No 
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